| Title |
Adenosine-diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus
|
|---|---|
| Published in |
Cochrane database of systematic reviews, November 2012
|
| DOI | 10.1002/14651858.cd005449.pub2 |
| Pubmed ID | |
| Authors |
Nyoli Valentine, Floris A Van de Laar, Mieke L van Driel |
| Abstract |
Cardiovascular disease (CVD) is the most prevalent complication of type 2 diabetes with an estimated 65% of people with type 2 diabetes dying from a cause related to atherosclerosis. Adenosine-diphosphate (ADP) receptor antagonists like clopidogrel, ticlopidine, prasugrel and ticagrelor impair platelet aggregation and fibrinogen-mediated platelet cross-linking and may be effective in preventing CVD. |
Twitter Demographics
The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 67% |
| United Kingdom | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | 1% |
| Spain | 1 | <1% |
| Ireland | 1 | <1% |
| China | 1 | <1% |
| Unknown | 190 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 36 | 18% |
| Researcher | 26 | 13% |
| Student > Bachelor | 23 | 12% |
| Student > Ph. D. Student | 13 | 7% |
| Student > Postgraduate | 12 | 6% |
| Other | 39 | 20% |
| Unknown | 46 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 87 | 45% |
| Nursing and Health Professions | 21 | 11% |
| Unspecified | 6 | 3% |
| Social Sciences | 5 | 3% |
| Agricultural and Biological Sciences | 4 | 2% |
| Other | 19 | 10% |
| Unknown | 53 | 27% |
Attention Score in Context
This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 August 2020.
All research outputs
#3,666,570
of 22,687,320 outputs
Outputs from Cochrane database of systematic reviews
#6,173
of 12,301 outputs
Outputs of similar age
#26,862
of 178,993 outputs
Outputs of similar age from Cochrane database of systematic reviews
#115
of 236 outputs
Altmetric has tracked 22,687,320 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,301 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 178,993 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 236 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.